Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Who is watching PDS

Re: Who is watching PDS

posted on Oct 12, 2009 04:22PM

Consolidated

Our other income and expenses for the three months ended August 31, 2009 included equity in the loss of PDS consisting of net loss after expenses in the amount of approximately $243,000 and our share of loss in Talis consisting of approximately $22,000 after expenses. For the three months ended August 31, 2008, our other income and expenses included our share of income in PDS of approximately $6,622,000 and our share of loss in Talis of approximately $63,000. Our investments in PDS and Talis are accounted for in accordance with the equity method of accounting for investments.

http://biz.yahoo.com/e/091009/ptsc.ob10-q.html

Share
New Message
Please login to post a reply